Focosi D - Search Results

1

Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy.

Casadevall A, Joyner MJ, Pirofski LA, Senefeld JW, Shoham S, Sullivan D, Paneth N, Focosi D. Casadevall A, et al. Among authors: focosi d. Expert Rev Respir Med. 2023 May;17(5):381-395. doi: 10.1080/17476348.2023.2208349. Epub 2023 May 2. Expert Rev Respir Med. 2023. PMID: 37129285 Review.

2

Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations.

Focosi D, Franchini M. Focosi D, et al. Expert Rev Vaccines. 2022 Jul;21(7):877-884. doi: 10.1080/14760584.2021.1932475. Epub 2021 May 27. Expert Rev Vaccines. 2022. PMID: 34015243 Free PMC article.

3

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors.

Focosi D, Franchini M, Pirofski LA, Burnouf T, Fairweather D, Joyner MJ, Casadevall A. Focosi D, et al. Viruses. 2021 Aug 11;13(8):1594. doi: 10.3390/v13081594. Viruses. 2021. PMID: 34452459 Free PMC article. Review.

4

Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics?

Focosi D, Franchini M, Pirofski LA, Maggi F, Casadevall A. Focosi D, et al. Rev Med Virol. 2022 Jul;32(4):e2314. doi: 10.1002/rmv.2314. Epub 2021 Dec 3. Rev Med Virol. 2022. PMID: 34861088 Review.

5

Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review.

Focosi D, Maggi F, Franchini M, McConnell S, Casadevall A. Focosi D, et al. Int J Mol Sci. 2021 Dec 21;23(1):29. doi: 10.3390/ijms23010029. Int J Mol Sci. 2021. PMID: 35008446 Free PMC article.

6

Are convalescent plasma stocks collected during former COVID-19 waves still effective against current SARS-CoV-2 variants?

Focosi D, Franchini M, Joyner MJ, Casadevall A. Focosi D, et al. Vox Sang. 2022 May;117(5):641-646. doi: 10.1111/vox.13239. Epub 2022 Jan 12. Vox Sang. 2022. PMID: 35023163 Review.

7

Convalescent plasma for COVID-19. TSUNAMI is not the final word.

Franchini M, Focosi D, Casadevall A, Joyner MJ, Perotti C. Franchini M, et al. Among authors: focosi d. Eur J Intern Med. 2022 Mar;97:116-118. doi: 10.1016/j.ejim.2022.01.016. Epub 2022 Jan 7. Eur J Intern Med. 2022. PMID: 35031215 Free PMC article. No abstract available.

8

Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis.

Focosi D, Maggi F, McConnell S, Casadevall A. Focosi D, et al. Antiviral Res. 2022 Feb;198:105247. doi: 10.1016/j.antiviral.2022.105247. Epub 2022 Jan 13. Antiviral Res. 2022. PMID: 35033572 Free PMC article.

9

Convalescent plasma in outpatients with COVID-19.

Focosi D, Casadevall A. Focosi D, et al. Lancet Respir Med. 2022 Mar;10(3):226-228. doi: 10.1016/S2213-2600(22)00050-9. Epub 2022 Feb 9. Lancet Respir Med. 2022. PMID: 35150608 Free PMC article. No abstract available.

10

Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic.

Focosi D, Maggi F, McConnell S, Casadevall A. Focosi D, et al. Future Microbiol. 2022 Mar;17:219-221. doi: 10.2217/fmb-2021-0286. Epub 2022 Feb 15. Future Microbiol. 2022. PMID: 35164530 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters